Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Lymphoma 1Heart Failure 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

pembrolizumab 7Cyclophosphamide 7Surveys and Questionnaires 4Filgrastim 4aldesleukin 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Nivolumab 3Methods 3Flow Cytometry 3Early Intervention, Educational 3valspodar 2sargramostim 2fludarabine 2atezolizumab 2Therapeutics 2Stem Cell Factor 2Sirolimus 2Methylprednisolone 2Melphalan 2Ipilimumab 2Interleukin-2 2Immunologic Techniques 2Exercise 2Etoposide 2Epoetin Alfa 2Educational Status 2Drug Therapy 2Data Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Secondary Prevention × Breast × Clear all
NCT05892146 2023-06-07

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

National Cheng-Kung University Hospital

Phase NA Unknown
100 enrolled
BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡